Bevacizumab vs Erlotinib

## Bevacizumab vs Erlotinib: Overview

This comparison examines the pharmacological differences between **Bevacizumab** and **Erlotinib**.

## Mechanism of Action

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

## Pharmacokinetics

**Half-life**: Bevacizumab — N/A; Erlotinib — 36 hours.

## Chemical Properties

**Molecular Formula**: Bevacizumab — N/A; Erlotinib — C22H23N3O4.

**Molecular Weight**: Bevacizumab — N/A; Erlotinib — 393.4380 g/mol.

**Type**: Bevacizumab — Antibody; Erlotinib — Small molecule.